AllOut Marketing, Inc. Announces Launch of Fosteum™ Website
MINNEAPOLIS, Minn. (October 15, 2007) – AllOut Marketing, Inc. announces the launch of the Fosteum™ website. Fosteum, a product of Primus Pharmaceuticals, is a prescription medical food product for the clinical dietary management in the metabolic processes of osteopenia and osteoporosis.
“Fosteum is a specially formulated medical food product that reduces bone breakdown and increases bone formation, unlike current drugs that focus only on breakdown,” said MaryAnn Armbruster, Brand Manager of Fosteum. “Our Fosteum website needed to educate the user about Fosteum and the emerging medical foods category, and communicate to two very distinct audiences. AllOut Marketing responded to our challenge and built an optimized website that serves as a resource and educational tool for the physician and the patient, and has two distinct, yet integrated user-paths.”
A nascent category in medical science, medical foods are intended for a specific diseased population and must be used under a physician’s supervision. Medical foods are an FDA-regulated category of products that must have therapeutic value based on recognized science. Fosteum consists of a proprietary blend of genistein aglycone (from soy) with citrated zinc bisglycinate (a special form of zinc) and cholecalciferol (vitamin D3).
AllOut Marketing exclusively serves the medical device, bioscience and pharmaceutical markets, offering specialized medical marketing consulting, graphic design, web site marketing strategy, event management, public relations and market research. From pre-product development through product launch and commercialization, AllOut Marketing has over ten years of worldwide experience in delivering effective and successful integrated marketing and creative communications campaigns. For more information about AllOut Marketing and medical product marketing visit www.alloutsuccess.com.
Primus Pharmaceuticals is the first pharmaceutical company to focus on prescription metabolic products dedicated to improving patient quality of life without compromising safety. Primus develops branded prescription drugs and medical foods that are proven safe and effective in chronic or recurring diseases. The Company’s needs-based process to develop first-line prescription products formulated to restore metabolic processes at the disease source (rather than masking symptoms) is novel and proprietary. Primus promotes to targeted physician specialists and extends its sales reach and clinical capabilities through strategic partnerships. All products are protected by composition of matter patents and other intellectual property. Primus is privately held and based in Scottsdale, Ariz. For more information, visit www.primusrx.com.
— Posted 10/15/2007